ACAD vs AVGO Stock Comparison
ACADIA Pharmaceuticals Inc. vs Broadcom Inc.
ACAD leads
ACAD leads by 23 AIQ points, primarily on Momentum and Value, and the lead has widened from 12 points over 30 sessions. Wall Street currently favors AVGO on target upside.
Competitive: 4 of 6 evidence groups support ACAD, its lead is widening, and its current signal state is conflicted.
ACADIA Pharmaceuticals Inc.
Broadcom Inc.
The Algovestiq AIQ Score currently favors ACAD over AVGO, 70 versus 47 as of Sep 5, 2026. ACAD's advantage is driven primarily by stronger momentum and value. ACAD also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 4 of 6 covered evidence groups favor ACAD today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. ACAD lead: Strengthening — the AIQ differential moved from 12 to 23 points over 30 sessions. ACAD leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.
Compare ACADIA Pharmaceuticals Inc. and Broadcom Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Compare ACAD and AVGO against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum25%59 vs 20ACAD +39
- Value30%57 vs 30ACAD +27
- Risk Resilience15%68 vs 52ACAD +16
- Quality30%92 vs 85ACAD +7
4 of 6 evidence groups favor ACAD. ACAD’s edge is concentrated in momentum and value.
What changed since the last close
Latest scored session 2026-09-03, compared against the prior scored session 2026-09-02.
Largest factor move: Momentum -5
New signals
- BB Lower Band Breach — bullish, volatility, short horizon
Largest factor move: Momentum -1
New signals
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.79%)
ACAD's lead was unchanged in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — ACAD and AVGO both carry a full feed there.
The central trade-off
ACAD (ACADIA Pharmaceuticals Inc.): the stronger current systematic profile, led by momentum and value.
AVGO (Broadcom Inc.): the counter-case, on fundamentals, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ACADACAD on the overall AIQ Score, which weights Quality and Value at 30% each.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
ACADACAD on the peer-relative Value factor, by 27 points.
Momentum
ACADACAD on the Momentum factor, by 39 points.
Lower downside
ACADACAD on Risk Resilience, by 16 points.
Analyst upside
AVGOAVGO on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ACAD, analyst targets favor AVGO. That disagreement is the most useful thing on this page.
| Measure | ACAD | AVGO | Note |
|---|---|---|---|
| Implied upside to target | +20.3% | +40.1% | AVGO has more room |
| Target dispersion | +102.3% | +36.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 9 | 15 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor ACAD. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ACAD | 70 vs 47 |
| Fundamentals | AVGOon balance | revenue growth 14.9% vs 14.9%; EPS growth 8% vs 26.5%; TTM ROE 32.4% vs 36.4%; gross margin 91.1% vs 67%; operating margin 7.6% vs 43.7% — AVGO takes 3 of 4 decided legs, not all of them |
| Valuation | ACAD | Value 57 vs 30 |
| Technicals | ACAD | Price vs 50-day 3% vs -6.8%; vs 200-day 14% vs -3.4% |
| Risk Resilience | ACAD | Risk Resilience 68 vs 52 |
| Analyst expectations | AVGO | Target upside 20.3% vs 40.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ACAD and AVGO and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 23 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ACAD.
How the comparison changed
120 daily snapshots · Apr 22 – Sep 3ACAD lead: Strengthening — the AIQ differential moved from 12 to 23 points over 30 sessions.
- Today
- ACAD +23
- 70 vs 47
- 7 sessions ago
- ACAD +24
- 69 vs 45
- 30 sessions ago
- ACAD +12
- 74 vs 62
- 90 sessions ago
- ACAD +25
- 74 vs 49
The lead changed hands 2 times in this window, most recently on Jun 4 when ACAD moved ahead of AVGO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (11.27%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- BB Lower Band Breach — bullish, volatility, short horizon
2 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (3.87%)
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.79%)
ACAD leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +0.57%, AIQ -1 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +0.21%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Momentum gap — currently 39 points behind, the largest single contributor to ACAD's edge.
- 2AVGO's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend.
- 3ACAD's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | ACAD | AVGO |
|---|---|---|
| Revenue growth (YoY) | 14.9% | 14.9% |
| EPS growth (YoY) | 8% | 26.5% |
| Gross margin | 91.1% | 67% |
| Operating margin | 7.6% | 43.7% |
| Return on equity (TTM) | 32.4% | 36.4% |
| Debt to equity | 0.06 | 0.74 |
Technicals
ACAD has the stronger structure| Metric | ACAD | AVGO |
|---|---|---|
| RSI (14) | 47.6 | 28.4 |
| ADX (14) | 32.9 | 22.7 |
| Price vs 50-day | 3% | -6.8% |
| Price vs 200-day | 14% | -3.4% |
| Volatility (1M, annualized) | 36.6% | 36.2% |
Risk
ACAD is the more resilient| Metric | ACAD | AVGO |
|---|---|---|
| Beta | 0.83 | 2.15 |
| Sharpe ratio | 0.3 | 0.51 |
| Sortino ratio | 0.48 | 0.76 |
| Max drawdown | -27.6% | -28.9% |
| Current drawdown | -8.9% | -25.8% |
| Annualized volatility | 38% | 48.5% |
| Value at risk (95%) | -3.5% | -4.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ACAD or AVGO?
On the Algovestiq AIQ Score, ACAD is the stronger of the two as of Sep 5, 2026, scoring 70 against AVGO's 47. The edge comes from momentum and value. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ACAD or AVGO the better buy right now?
ACAD carries the stronger systematic profile as of Sep 5, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor ACAD over AVGO?
The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. ACAD leads Momentum by 39 points; ACAD leads Value by 27 points; ACAD leads Risk Resilience by 16 points. ACAD leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by AVGO simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.
Which has more analyst upside, ACAD or AVGO?
Analyst price targets imply +20.3% upside for ACAD and +40.1% for AVGO, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors ACAD. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ACAD or AVGO?
ACAD is the better-valued of the two on the peer-relative Value factor. ACAD on the peer-relative Value factor, by 27 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ACAD or AVGO?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ACAD or AVGO?
ACAD on the Momentum factor, by 39 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ACAD or AVGO?
ACAD is the more resilient of the two, so the other name carries the higher downside risk. ACAD on Risk Resilience, by 16 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ACAD more profitable than AVGO?
The profitability evidence is mixed: gross margin 91.1% vs 67%; operating margin 7.6% vs 43.7%; ttm roe 32.4% vs 36.4%. ACAD leads on one measure and AVGO on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is ACAD's lead over AVGO getting stronger or weaker?
ACAD lead: Strengthening — the AIQ differential moved from 12 to 23 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-04-22 and 2026-09-03. The lead has changed hands 2 times in that window, most recently on 2026-06-04, when ACAD moved ahead of AVGO.
What would change the ACAD vs AVGO verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Momentum gap — currently 39 points behind, the largest single contributor to ACAD's edge; AVGO's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend; ACAD's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.
What do the current signals say about ACAD and AVGO?
ACAD: 4 bullish / 1 bearish / 1 neutral, conflicted. AVGO: 2 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ACAD is Golden Cross Active (bullish, long horizon). On AVGO it is Golden Cross Active (bullish, long horizon).
Compare ACAD and AVGO with others
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.